Correlation Between Zimmer Biomet and SCANDMEDICAL SOLDK-040

Can any of the company-specific risk be diversified away by investing in both Zimmer Biomet and SCANDMEDICAL SOLDK-040 at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Zimmer Biomet and SCANDMEDICAL SOLDK-040 into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Zimmer Biomet Holdings and SCANDMEDICAL SOLDK 040, you can compare the effects of market volatilities on Zimmer Biomet and SCANDMEDICAL SOLDK-040 and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Zimmer Biomet with a short position of SCANDMEDICAL SOLDK-040. Check out your portfolio center. Please also check ongoing floating volatility patterns of Zimmer Biomet and SCANDMEDICAL SOLDK-040.

Diversification Opportunities for Zimmer Biomet and SCANDMEDICAL SOLDK-040

0.08

Correlation Coefficient

Zimmer Biomet  SCANDMEDICAL SOLDK-040

Significant diversification

The 3 months correlation between Zimmer and SCANDMEDICAL is 0.08. Overlapping area represents the amount of risk that can be diversified away by holding Zimmer Biomet Holdings and SCANDMEDICAL SOLDK 040 in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on SCANDMEDICAL SOLDK 040 and Zimmer Biomet is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Zimmer Biomet Holdings are associated (or correlated) with SCANDMEDICAL SOLDK-040. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of SCANDMEDICAL SOLDK 040 has no effect on the direction of Zimmer Biomet i.e., Zimmer Biomet and SCANDMEDICAL SOLDK-040 go up and down completely randomly.

Pair Corralation between Zimmer Biomet and SCANDMEDICAL SOLDK-040

Assuming the 90 days horizon Zimmer Biomet Holdings is expected to generate 0.46 times more return on investment than SCANDMEDICAL SOLDK-040. However, Zimmer Biomet Holdings is 2.18 times less risky than SCANDMEDICAL SOLDK-040. It trades about 0.01 of its potential returns per unit of risk. SCANDMEDICAL SOLDK 040 is currently generating about -0.02 per unit of risk. If you would invest  10,071  in Zimmer Biomet Holdings on October 9, 2024 and sell it today you would earn a total of  24.00  from holding Zimmer Biomet Holdings or generate 0.24% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Insignificant
Accuracy	97.37%
Values	Daily Returns

Zimmer Biomet Holdings  vs.  SCANDMEDICAL SOLDK 040

Zimmer Biomet Holdings

Risk-Adjusted Performance

9 of 100

OK

Compared to the overall equity markets, risk-adjusted returns on investments in Zimmer Biomet Holdings are ranked lower than 9 (%) of all global equities and portfolios over the last 90 days. Despite nearly fragile basic indicators, Zimmer Biomet may actually be approaching a critical reversion point that can send shares even higher in February 2025.

SCANDMEDICAL SOLDK 040

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days SCANDMEDICAL SOLDK 040 has generated negative risk-adjusted returns adding no value to investors with long positions. Despite nearly stable basic indicators, SCANDMEDICAL SOLDK-040 is not utilizing all of its potentials. The current stock price disturbance, may contribute to mid-run losses for the stockholders.

Pair Trading with Zimmer Biomet and SCANDMEDICAL SOLDK-040

The main advantage of trading using opposite Zimmer Biomet and SCANDMEDICAL SOLDK-040 positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Zimmer Biomet position performs unexpectedly, SCANDMEDICAL SOLDK-040 can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in SCANDMEDICAL SOLDK-040 will offset losses from the drop in SCANDMEDICAL SOLDK-040's long position.

The idea behind Zimmer Biomet Holdings and SCANDMEDICAL SOLDK 040 pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Premium Stories module to follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope.